M. Rijk

Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial

F. Vleggaar, P. Fockens, R. V. D. van der Hulst, 2016, Trials.

Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.

M. Rijk, A. van Schaik, J. V. van Tongeren, 1988, Scandinavian journal of gastroenterology.

Sulphasalazine and prednisone compared with sulphasalazine for treating active Crohn disease. A double-blind, randomized, multicenter trial.

H. V. van Lier, R. V. van Hogezand, M. Rijk, 1991, Annals of internal medicine.

Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea.

M. Rijk, A. van Schaik, J. V. van Tongeren, 1992, Scandinavian journal of gastroenterology.

Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid-delivering drugs during accelerated intestinal transit in healthy volunteers.

R. V. van Hogezand, M. Rijk, A. van Schaik, 1989, Scandinavian journal of gastroenterology.

Symptomatic hypocalcemia after sodium phosphate preparation in an adult with asymptomatic hypoparathyroidism.

M. Rijk, C. van Guldener, Nicolasine D. Niemeijer, 2008, European journal of gastroenterology & hepatology.

Relapse-preventing effect and safety of sulfasalazine and olsalazine in patients with ulcerative colitis in remission: a prospective, double-blind, randomized multicenter study. The Ulcerative Colitis Multicenter Study Group.

H. V. van Lier, M. Rijk, J. V. van Tongeren, 1992, The American journal of gastroenterology.

Intravenous Pinacidil in the Acute Treatment of Hypertension

T. Thien, M. Rijk, 1987, Journal of clinical pharmacology.

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.

W. Hop, F. T. ten Kate, H. V. van Buuren, 1998, Journal of hepatology.